Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

SIMPLE SUMMARY: Recently, the introduction of immunotherapy radically changed the therapeutic algorithm of non-small-cell lung cancer as an upfront or secondary strategy. Unfortunately, the small amount of patient benefits from immune-checkpoint inhibitors (ICI) and the prognostic role of concomitan...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: De Giglio, Andrea, Mezquita, Laura, Auclin, Edouard, Blanc-Durand, Félix, Riudavets, Mariona, Caramella, Caroline, Martinez, Gala, Benitez, Jose Carlos, Martín-Romano, Patricia, El-Amarti, Lamiae, Hendriks, Lizza, Ferrara, Roberto, Naltet, Charles, Lavaud, Pernelle, Gazzah, Anas, Adam, Julien, Planchard, David, Chaput, Nathalie, Besse, Benjamin
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599488/
https://ncbi.nlm.nih.gov/pubmed/33007977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102827
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items